⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO
IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading
globenewswire.com
AMGN
BMY
SNY
Spago Nanomedical Interim Report January-March 2026
accessnewswire.com
TLRY
BMY
REGN
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
businesswire.com
BMY
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
Breast Cancer Canada’s annual Walk-a-Thon to Mother’s Day returns to advance breast cancer research.
businesswire.com
AMGN
MRK
PFE
BMY
GILD
ABBV
AZN
JNJ
LULU
The Michael J. Fox Foundation Announces Landmark Parkinson's Study Enters New Era of Precision Medicine
prnewswire.com
BMY
LLY
GC Therapeutics Appoints Stem Cell Therapy Leader Stefan Irion, MD, as Chief Scientific Officer
businesswire.com
BMY
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
globenewswire.com
BNTX
PFE
BMY
Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer
globenewswire.com
BMY
GS
MS
ABBV